<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00001158</url>
  </required_header>
  <id_info>
    <org_study_id>770066</org_study_id>
    <secondary_id>77-C-0066</secondary_id>
    <nct_id>NCT00001158</nct_id>
  </id_info>
  <brief_title>Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System</brief_title>
  <official_title>Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institutes of Health Clinical Center (CC)</source>
  <brief_summary>
    <textblock>
      The goal of the protocol is to define the normal humoral and cellular immune responses to
      antigens in volunteers and to define abnormalities of these immune responses in patients with
      immunodeficiency diseases or cancer. In vitro assays and in vivo skin tests and immunization
      with antigens will be utilized.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The goal of the protocol is to define the normal humoral and cellular immune responses to
      antigens in volunteers and to define abnormalities of these immune responses in patients with
      immunodeficiency diseases or cancer. In vitro assays and in vivo skin tests and immunization
      with antigens will be utilized.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 1977</start_date>
  <completion_date>March 2000</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <condition>Immunologic Deficiency Syndromes</condition>
  <condition>Neoplasms</condition>
  <eligibility>
    <criteria>
      <textblock>
        Patients will be studied if a disorder of the immune system is suspected.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>National Cancer Institute (NCI)</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20892</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Nelson DL, Blaese RM, Strober W, Bruce R, Waldmann TA. Constrictive pericarditis, intestinal lymphangiectasia, and reversible immunologic deficiency. J Pediatr. 1975 Apr;86(4):548-54.</citation>
    <PMID>1127501</PMID>
  </reference>
  <verification_date>April 1999</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 3, 1999</study_first_submitted>
  <study_first_submitted_qc>December 9, 2002</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 10, 2002</study_first_posted>
  <last_update_submitted>March 4, 2008</last_update_submitted>
  <last_update_submitted_qc>March 4, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 5, 2008</last_update_posted>
  <keyword>Cellular Immunity</keyword>
  <keyword>Humoral Immunity</keyword>
  <keyword>Immunodeficiency Disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Immunologic Deficiency Syndromes</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

